Overpatented, Overpriced – I-MAK

Revealing drugmakers' abuse of patent law in the U.S. across the 12 best selling drugs:

Read the Report

Across the top 12 grossing drugs in America there are on average:

125

patent applications filed,
and 71 granted patents
per drug
68%

price increase since 2012;
only one drug
decreased in price
38

years of attempted
patent protection
blocking generic competition

Want to dive deeper?

access our dataset

Or read on of our individual drug briefs:

Humira

Largest number of patent applications in the top 12

Lantus

95% of its patent applications were filed AFTER it was on the market

Enbrel

One of the largest price hikes in the last 6 years

Imbruvica

Over half of its patents are for indications, not the drug itself

Spread the word!

Download and share these graphics

Summary of the top 12 drugs

Key stats gif

Playing the patent game

Revlimid

Lyrica

Lantus

Avastin

Humira

Rituxan

Partner with us now to build
a more just and equitable
medicine system for all.